港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

科伦博泰生物-B

310.400

-4.600-1.46%

成交量：15.18万

成交额：4,789.11万

市值：704.61亿

市盈率：-238.23

高：323.200

开：315.000

低：308.400

收：315.000

数据加载中...

总览公司新闻资讯公告

科伦博泰生物-B盘中异动临近午盘股价大涨5.12%报170.500港元

港股异动 | 科伦博泰生物-B(06990)再涨近5% 和铂医药宣布HBM9378/SKB378获批临床试验

科伦博泰生物-B拟实施H股全流通

【科伦博泰生物-B(06990.HK)拟实施H股全流通】科伦博泰生物-B(06990.HK)发布公告，公司董事会已审议及批准公司若干股东所持不超过约2542.12万股公司内资股拟实施全流通(“H股全流通”)。同日，公司已向中国证监会提交关于H股全流通的备案申请。

科伦博泰生物-B(06990)拟实施H股全流通

科伦博泰生物-B盘中异动股价大跌5.04%报160.200港元

科伦博泰生物－Ｂ(06990)股价下跌5.039%，现价港币$160.2

阿斯达克财经

格隆汇个股放量排行榜 | 1月26日

科伦博泰生物-B盘中异动早盘股价大涨5.09%

科伦博泰生物-B01月23日主力资金流出277万元连续3日减仓

科伦博泰生物签署多个结构性存款协议金额超4亿元

科伦博泰生物(06990.HK)认购银行结构性存款

阿斯达克财经

科伦博泰生物-B认购结构性存款

格隆汇资讯

科伦博泰生物-B盘中异动临近收盘股价大跌5.19%报159.000港元

科伦博泰生物(06990.HK)SKB445新药临床试验申请获批准

阿斯达克财经

科伦博泰生物(06990.HK)抗PD-L1塔戈利单抗获上市批准

阿斯达克财经

科伦博泰生物-B新药抗PD-L1塔戈利单抗获批上市

科伦博泰生物获SKB445新药临床试验通知书

科伦博泰生物-B(06990)：抗PD-L1塔戈利单抗获国家药监局批准上市

科伦博泰生物-B(06990)：SKB445新药临床试验申请获国家药品监督管理局批准

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/06990/news?page=7"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科伦博泰生物-B","latestPrice":310.4,"timestamp":1747193438246,"preClose":315,"halted":0,"volume":151824,"delay":0,"floatShares":157000000,"shares":227000000,"eps":-1.3021896623762836,"marketStatus":"交易中","change":-4.6,"latestTime":"05-14 11:30:46","open":315,"high":323.2,"low":308.4,"amount":47891104,"amplitude":0.046984,"askPrice":310.4,"askSize":100,"bidPrice":310,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.3021896623762836,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1747195200000},"marketStatusCode":2,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":315,"openAndCloseTimeList":[[1747186200000,1747195200000],[1747198800000,1747209600000]],"volumeRatio":0.506211,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":157000000,"roa":"-3.41%","roe":"-9.46%","lyrEps":-1.30293,"volumeRatio":0.506211,"shares":227000000,"dividePrice":0,"high":323.2,"amplitude":0.046984,"preClose":315,"low":308.4,"week52Low":120.2,"pbRate":"19.67","psRate":"33.67","week52High":360,"institutionHeld":0,"latestPrice":310.4,"eps":-1.3029304291549835,"divideRate":0,"volume":151824,"delay":0,"ttmEps":-1.3029304291549835,"open":315,"prevYearClose":163.3,"prevWeekClose":321,"prevMonthClose":332.8,"prevQuarterClose":290.8,"fiveDayClose":315,"twentyDayClose":280.8,"sixtyDayClose":178.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2509294335","title":"科伦博泰生物-B盘中异动 临近午盘股价大涨5.12%报170.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509294335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509294335?lang=zh_cn&edition=fundamental","pubTime":"2025-02-06 11:38","pubTimestamp":1738813113,"startTime":"0","endTime":"0","summary":"2025年02月06日临近午盘11时38分，科伦博泰生物-B股票出现波动，股价快速拉升5.12%。截至发稿，该股报170.500港元/股，成交量6.97万股，换手率0.05%，振幅7.21%。资金方面，该股资金流入549.859万港元，流出484.681万港元。科伦博泰生物-B股票所在的生物技术行业中，整体涨幅为1.84%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206113833abc42bea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206113833abc42bea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2509291645","title":"港股异动 | 科伦博泰生物-B(06990)再涨近5% 和铂医药宣布HBM9378/SKB378获批临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2509291645","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509291645?lang=zh_cn&edition=fundamental","pubTime":"2025-02-06 11:26","pubTimestamp":1738812419,"startTime":"0","endTime":"0","summary":"消息面上，和铂医药宣布，集团针对胸腺基质淋巴细胞生成素的全人源单克隆抗体HBM9378/SKB378已获得国家药监局药品审评中心的新药研究申请批件，以开展治疗慢性阻塞性肺病的临床试验。据悉，HBM9378/SKB378为公司与科伦博泰开展的共同开发项目，二者共同享有大中华地区及多个东南亚及西亚国家的权利。此前，NMPA已批准塔戈利单抗单药用于治疗既往接受过2线及以上化疗失败的复发或转移性鼻咽癌患者于中国上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1246432.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","02142","BK1161","06990","BK1576","BK1574","BK1141","BK1583","LU0196878994.USD"],"gpt_icon":0},{"id":"2508345150","title":"科伦博泰生物-B拟实施H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2508345150","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508345150?lang=zh_cn&edition=fundamental","pubTime":"2025-02-03 08:47","pubTimestamp":1738543620,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　科伦博泰生物-B（06990）发布公告，公司董事会已审议及批准公司若干股东所持不超过约2542.12万股公司内资股拟实施全流通（“H股全流通”）。同日，公司已向中国证监会提交关于H股全流通的备案申请。\n　　于本公告日期，H股全流通尚须取得所有相关批准（包括中国证监会的备案通知），以及将该等股份转换为本公司H股及香港联合交易所有限公司上市委员会批准H股于联交所主板上市及买卖（“转换并上市”）。H股全流通最终实施数量将取决于该等相关批准情况。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-03/doc-ineiefen5349729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2506159060","title":"【科伦博泰生物-B(06990.HK)拟实施H股全流通】科伦博泰生物-B(06990.HK)发布公告，公司董事会已审议及批准公司若干股东所持不超过约2542.12万股公司内资股拟实施全流通(“H股全流通”)。同日，公司已向中国证监会提交关于H股全流通的备案申请。","url":"https://stock-news.laohu8.com/highlight/detail?id=2506159060","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506159060?lang=zh_cn&edition=fundamental","pubTime":"2025-01-28 20:20","pubTimestamp":1738066850,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B(06990.HK)发布公告，公司董事会已审议及批准公司若干股东所持不超过约2542.12万股公司内资股拟实施全流通(“H股全流通”)。同日，公司已向中国证监会提交关于H股全流通的备案申请。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/28202047881455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2506262597","title":"科伦博泰生物-B(06990)拟实施H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2506262597","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506262597?lang=zh_cn&edition=fundamental","pubTime":"2025-01-28 20:07","pubTimestamp":1738066023,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B(06990)发布公告，公司董事会已审议及批准公司若干股东所持不超过约2542.12万股公司内资股拟实施全流通(“H股全流通”)。同日，公司已向中国证监会提交关于H股全流通的备案申请。于本公告日期，H股全流通尚须取得所有相关批准(包括中国证监会的备案通知)，以及将该等股份转换为本公司H股及香港联合交易所有限公司上市委员会批准H股于联交所主板上市及买卖(“转换并上市”)。H股全流通最终实施数量将取决于该等相关批准情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1244984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2506345703","title":"科伦博泰生物-B盘中异动 股价大跌5.04%报160.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506345703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506345703?lang=zh_cn&edition=fundamental","pubTime":"2025-01-27 13:40","pubTimestamp":1737956433,"startTime":"0","endTime":"0","summary":"2025年01月27日下午盘13时40分，科伦博泰生物-B股票出现波动，股价大幅下挫5.04%。截至发稿，该股报160.200港元/股，成交量5.77万股，换手率0.04%，振幅5.75%。资金方面，该股资金流入300.043万港元，流出449.605万港元。科伦博泰生物-B股票所在的生物技术行业中，整体涨幅为0.39%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012713403398743e0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012713403398743e0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2506345161","title":"科伦博泰生物－Ｂ(06990)股价下跌5.039%，现价港币$160.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2506345161","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506345161?lang=zh_cn&edition=fundamental","pubTime":"2025-01-27 13:40","pubTimestamp":1737956400,"startTime":"0","endTime":"0","summary":"[下跌股]科伦博泰生物－Ｂ(06990) 股价在下午01:40比前收市价下跌5.039%，现股价为港币$160.2。至目前为止，今日最高价为$169.9，而最低价为$160.2。总成交量为5.77万股，总成交金额为港币$944.697万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2501271795/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2506335863","title":"格隆汇个股放量排行榜 | 1月26日","url":"https://stock-news.laohu8.com/highlight/detail?id=2506335863","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506335863?lang=zh_cn&edition=fundamental","pubTime":"2025-01-26 17:30","pubTimestamp":1737883803,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日EDA集团控股(02505)、粤海置地(00124)、赛伯乐国际控股(01020)、出门问问(02438)、商汤-WR(80020)、畅捷通(01588)、京东方精电(00710)、地平线机器人-W(09660)、第四范式(06682)、连连数字(02598)、中国智能科技(00464)、满贯集团(03390)、美团-WR(83690)、FIT HON TENG(0","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/26173047831469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["00565","02359","01815","01020","02038","02799","00204","02505","09995","02236","06990","01186","02155","06601","00631","02196","06055","03709","01880","06996","06626","03339","00815","00511","06060","02309","01728","06682","00288","00241","01302","01997","00659","00697","00370","01357","01252","00464","00308","02460","06616","03931","00124","01088","00264","00412"],"gpt_icon":1},{"id":"2505008651","title":"科伦博泰生物-B盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505008651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505008651?lang=zh_cn&edition=fundamental","pubTime":"2025-01-24 10:32","pubTimestamp":1737685947,"startTime":"0","endTime":"0","summary":"2025年01月24日早盘10时32分，科伦博泰生物-B股票出现异动，股价快速拉升5.09%。截至发稿，该股报171.300港元/股，成交量4.25万股，换手率0.03%，振幅5.09%。科伦博泰生物-B股票所在的生物技术行业中，整体涨幅为0.66%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124103227abb690ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124103227abb690ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","LU0196878994.USD","BK1161"],"gpt_icon":0},{"id":"2505065003","title":"科伦博泰生物-B01月23日主力资金流出277万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2505065003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505065003?lang=zh_cn&edition=fundamental","pubTime":"2025-01-23 16:15","pubTimestamp":1737620140,"startTime":"0","endTime":"0","summary":"01月23日, 科伦博泰生物-B股价涨2.07%，报收163.00元，成交金额2941万元，换手率0.14%，振幅5.01%，量比0.96。科伦博泰生物-B今日主力资金净流出277万元，连续3日净流出，上一交易日主力净流出159万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为72.73%，平均跌幅为2.40%。该股近5个交易日上涨2.00%，主力资金累计净流出380万元；近20日主力资金累计净流出1184万元，其中净流出天数为8日。该股主力净额占比0.01%，港股市场排名2471/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123161601abb59542&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123161601abb59542&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2505760651","title":"科伦博泰生物签署多个结构性存款协议 金额超4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505760651","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505760651?lang=zh_cn&edition=fundamental","pubTime":"2025-01-22 14:42","pubTimestamp":1737528174,"startTime":"0","endTime":"0","summary":"财中社1月22日电科伦博泰生物-B（06990）发布公告，近日公司与中信银行、浙商银行及招商银行签订了多个结构性存款协议。具体而言，公司同意向中信银行认购本金为5000万元的结构性存款，以及向浙商银行认购两笔各为1亿元的结构性存款。此外，公司还与招商银行签订了本金为2亿元的结构性存款协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501223304703877.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2505737082","title":"科伦博泰生物(06990.HK)认购银行结构性存款","url":"https://stock-news.laohu8.com/highlight/detail?id=2505737082","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505737082?lang=zh_cn&edition=fundamental","pubTime":"2025-01-22 08:26","pubTimestamp":1737505560,"startTime":"0","endTime":"0","summary":"科伦博泰生物(06990.HK) 公布，认购中信银行(00998.HK) 本金额为5,000万元人民币(下同)的结构性存款。目前，公司向中信银行购买的理财产品的未到期本金总额为3亿元。公司另向浙商银行(02016.HK) 认购两笔结构性存款，每笔本金额为1亿元。目前，公司存置于浙商银行的结构性存款的未偿还本金总额为3.5亿元。此外，公司向招商银行(03968.HK) 认购一笔结构性存款，本金额为2亿元。(jl/w)(港股报价延迟最少十五分钟。沽空资料截至 2025-01-21 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230904161536655_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230904161536655_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1412270/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["161121","LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2505319677","title":"科伦博泰生物-B认购结构性存款","url":"https://stock-news.laohu8.com/highlight/detail?id=2505319677","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505319677?lang=zh_cn&edition=fundamental","pubTime":"2025-01-22 07:41","pubTimestamp":1737502915,"startTime":"0","endTime":"0","summary":"格隆汇1月22日丨科伦博泰生物-B发布公告，2025年1月21日，公司订立中信银行结构性存款协议III，据此，公司同意向中信银行认购本金额为人民币5000万元的结构性存款。于本公告日期，存置于浙商银行的结构性存款的未偿还本金总额为人民币3.50亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122074201960c1b47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122074201960c1b47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2505214875","title":"科伦博泰生物-B盘中异动 临近收盘股价大跌5.19%报159.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505214875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505214875?lang=zh_cn&edition=fundamental","pubTime":"2025-01-21 15:37","pubTimestamp":1737445069,"startTime":"0","endTime":"0","summary":"2025年01月21日临近收盘15时37分，科伦博泰生物-B股票出现波动，股价急速下挫5.19%。截至发稿，该股报159.000港元/股，成交量21.8万股，换手率0.17%，振幅5.90%。资金方面，该股资金流入1758.35万港元，流出1492.15万港元。科伦博泰生物-B股票所在的生物技术行业中，整体涨幅为0.12%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121153749abb2d00e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121153749abb2d00e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2505238683","title":"科伦博泰生物(06990.HK)SKB445新药临床试验申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2505238683","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505238683?lang=zh_cn&edition=fundamental","pubTime":"2025-01-21 00:42","pubTimestamp":1737391320,"startTime":"0","endTime":"0","summary":"科伦博泰生物－Ｂ(06990.HK) 公布，创新药物SKB445的新药临床试验申请已获国家药品监督管理局药品审评中心批准。SKB445是一款由公司针对靶点生物学特点，利用OptiDC平台技术研发的具有自主知识产权的新型ADC药物。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-01-20 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1411876/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0196878994.USD","BK1161","BK1576","BK1583","03347","BK1141","06990"],"gpt_icon":0},{"id":"2505238501","title":"科伦博泰生物(06990.HK)抗PD-L1塔戈利单抗获上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2505238501","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505238501?lang=zh_cn&edition=fundamental","pubTime":"2025-01-21 00:42","pubTimestamp":1737391320,"startTime":"0","endTime":"0","summary":"科伦博泰生物－Ｂ(06990.HK) 公布，公司联合顺铂和吉西他滨用于一线治疗复发或转移性鼻咽癌患者的靶向程序性细胞死亡配体1(PD-L1)的创新人源化单克隆抗体塔戈利单抗(科泰莱)已获中国国家药品监督管理局批准于中国上市。这是塔戈利单抗获批的第二项适应症。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-01-20 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20191009132908649_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20191009132908649_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1411877/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2504040445","title":"科伦博泰生物-B新药抗PD-L1塔戈利单抗获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2504040445","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504040445?lang=zh_cn&edition=fundamental","pubTime":"2025-01-20 20:21","pubTimestamp":1737375681,"startTime":"0","endTime":"0","summary":"财中社1月20日电科伦博泰生物-B（06990）发布公告，公司的抗PD-L1单抗塔戈利单抗（前称KL-A167）已获得中国国家药品监督管理局批准上市。该药物用于一线治疗复发或转移性鼻咽癌患者，联合顺铂和吉西他滨的治疗方案在有效性和安全性方面表现优异。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501203302386677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1169590202.USD","PD","LU0196878994.USD","BK1161","06990","LU1169589451.USD","BK4023"],"gpt_icon":0},{"id":"2504402224","title":"科伦博泰生物获SKB445新药临床试验通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2504402224","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504402224?lang=zh_cn&edition=fundamental","pubTime":"2025-01-20 20:21","pubTimestamp":1737375660,"startTime":"0","endTime":"0","summary":"财中社1月20日电科伦博泰生物-B（06990）发布公告，宣布公司已于2025年1月20日收到国家药品监督管理局药品审评中心同意公司开发的创新药物SKB445新药临床试验申请的临床试验通知书。SKB445是一款由公司针对靶点生物学特征，利用OptiDCTM平台技术研发的具有自主知识产权的新型ADC药物，临床前研究显示出良好的疗效和安全性，计划用于治疗晚期实体瘤。公告中提到，SKB445的最终成功开发及商业化仍存在不确定性，公司提醒股东及潜在投资者在买卖公司证券时需谨慎行事。（文章来源：财中社）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120202920960a48fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120202920960a48fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","LU0196878994.USD","BK1161","BK1141","03347","06990","BK1583"],"gpt_icon":0},{"id":"2504401512","title":"科伦博泰生物-B(06990)：抗PD-L1塔戈利单抗获国家药监局批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2504401512","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504401512?lang=zh_cn&edition=fundamental","pubTime":"2025-01-20 20:09","pubTimestamp":1737374944,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B 发布公告，公司联合顺铂和吉西他滨用于一线治疗复发或转移性鼻咽癌患者的靶向程序性细胞死亡配体1的创新人源化单克隆抗体塔戈利单抗(科泰莱)已获中国国家药品监督管理局批准于中国上市。本次获批主要基于一项评价塔戈利单抗联合顺铂和吉西他滨对照安慰剂联合顺铂和吉西他滨治疗复发或转移性鼻咽癌的有效性和安全性的随机、双盲、安慰剂对照、多中心III期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1169590202.USD","06990","LU0196878994.USD","BK1161","BK4023","LU1169589451.USD","PD"],"gpt_icon":0},{"id":"2504401834","title":"科伦博泰生物-B(06990)：SKB445新药临床试验申请获国家药品监督管理局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2504401834","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504401834?lang=zh_cn&edition=fundamental","pubTime":"2025-01-20 20:05","pubTimestamp":1737374714,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B(06990)发布公告，该公司董事会欣然宣布，公司已于2025年1月20日收到国家药品监督管理局药品审评中心同意公司开发的创新药物SKB445新药临床试验申请的临床试验通知书。SKB445是一款由公司针对靶点生物学特点，利用OptiDCTM平台技术研发的具有自主知识产权的新型ADC药物，在临床前研究中显示出良好的疗效和安全窗，拟用于治疗晚期实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK1161","BK1583","03347","06990","LU0196878994.USD","BK1141"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盘后","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盘后","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-28","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2941,"buy":0.7059,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7059,"analysts":17,"updateTime":1744646400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2025-05-13","current":-242.952086,"percent":0.028761,"low":-274.570331,"twenty":-162.700201,"median":-70.349644,"eighty":-45.208152,"high":-21.029201,"avg":-102.189651,"sd":66.556728,"marketCap":70127120385},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-13","current":-242.952086,"twenty":-162.700201,"median":-70.349644,"eighty":-45.208152,"marketCap":70127120385}],"updateTime":1747193446365}}}